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RESEARCH ARTICLE
Estimation of acute and chronic Q 
fever incidence in children during a three-year 
outbreak in the Netherlands and a comparison 
with international literature
Edwin N. E. Slok1*, Frederika Dijkstra1, Esther de Vries2, Ariene Rietveld3, Albert Wong1,4, Daan W. Notermans1 
and Jim E. van Steenbergen1,5
Abstract 
Background: In the Dutch 2007–2009 Q fever outbreak Coxiella burnetii was transmitted aerogenically from dairy 
goat farms to those living in the surrounding areas. Relatively few children were reported. The true number of pediat-
ric infections is unknown. In this study, we estimate the expected number of acute and chronic childhood infections.
Methods: As Coxiella was transmitted aerogenic to those living near infected dairy goat farms, we could use adult 
seroprevalence data to estimate infection risk for inhabitants, children and adults alike. Using Statistics Netherlands 
data we estimated the number of children at (high) risk for developing chronic Q fever. Literature was reviewed for 
childhood (0–15 years) Q fever reports and disease rates. We compared this with Dutch reported and our estimated 
data for 2007–2009.
Results: In The Netherlands epidemic, 44 children were reported (1.2 % of total notifications). The childhood inci-
dence was 0.15 compared to 2.6 per 10,000 inhabitants for adults. No complications were reported. Based on the 
expected similarity in childhood and adult exposure we assume that 9.8 % of children in the high-risk area had Q fever 
infection, resulting in 1562 acute infections during the Q fever epidemic interval. Based on the prevalence of con-
genital heart disease, at least 13 children are at high risk for developing chronic Q fever. In medical literature, 42 case 
reports described 140 childhood Q fever cases with a serious outcome (four deaths). In chronic Q fever, cardiac infec-
tions were predominant. Four outbreaks were reported involving children, describing 11 childhood cases. 36 National 
and/or regional studies reported seroprevalences varying between 0 and 70 %.
Conclusion: In the 3-year Dutch epidemic, few childhood cases were reported, with pulmonary symptoms lead-
ing, and none with a serious presentation. With an estimated 13 high-risk children for chronic infection in the high 
exposure area, and probably forty in the whole country, we may expect several chronic Q fever complications in the 
coming years in paediatric practice.
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Background
Between 2007 and 2009, a three-year cumulative epi-
demic of Q fever occurred, mainly in the Southern part 
of the Netherlands [1]. Over this period, more than 4000 
patients were reported to Municipal Health Services 
(MHS).
The most important mode of transmission during 
this epidemic was an airborne spread of the causative 
micro-organism Coxiella burnetii from infected dairy 
goat farms to surrounding living areas. Exposure risk 
was related to proximity of living near infected farms for 
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adults and children [2–5]. The epidemic ended after vac-
cination of the complete Dutch dairy goat population.
During this epidemic hardly any children under the age 
of 15 years were reported [6]. This could be expected as Q 
fever in children has been described as mild or asympto-
matic (60 %), only sporadically leading to serious compli-
cations [2, 7–10]. The most reported “classical” symptom 
is unexplained fever, a query, attributing to its name [11].
Many mild Coxiella infections may have been missed in 
the Netherlands because general practitioners generally 
do not perform laboratory tests in children with self-lim-
iting fever of unknown origin. The Dutch guideline “Chil-
dren with fever” (M29, May 2008) of the Dutch College 
of General Practitioners (NHG) recommends to perform 
only urinalysis for leukocytes and nitrite in mildly ill chil-
dren, and to consider performing a chest X-ray in case of 
suspected pneumonia. Microbiological diagnostic tests 
will rarely be performed in mildly ill children with fever. 
Therefore, the true number of Q fever in children during 
the Dutch epidemic remains unknown. Furthermore, all 
asymptomatic infections of course remained undetected.
Coxiella infected individuals with particular condi-
tions, e.g. immunosuppression, congenital heart disease, 
heart valve lesion or vascular abnormalities are more 
likely to develop chronic Q fever [12–14]. Thus, in the 
coming years an unknown number of chronic Q fever 
may become unveiled in the geographical area where Q 
fever cases were abundant.
In this article, we present an overview of reported 
Q fever cases during the 2007–2009 epidemic in The 
Netherlands. Based on this, we have estimated the likely 
total number of childhood infections, and subsequently 
the expected number of chronic infections in high-risk 




In the Netherlands, physicians are statutorily required 
to report Q fever patients to the Municipal Health Ser-
vice (MHS). All Dutch laboratories report positive sero-
logical findings of recent Q fever to the MHS. The MHS 
takes local action and daily reports anonymised patient 
data through the electronic registration system of legally 
reported infectious diseases (Osiris) to the Centre of 
Infectious Diseases Control of the National Institute for 
Public Health and the Environment (RIVM). Amongst 
others, age, gender and postal code are registered. Report-
ing criteria for Q fever are fever, or pneumonia or hepa-
titis in combination with laboratory confirmation of Q 
fever (by serology or PCR). Strictly speaking, clinical pic-
tures without fever (e.g. encephalitis) are not reportable 
but in practice, such cases are usually included as proven 
Q fever. Children were included in our study if they were 
reported by the MHS in Osiris and if they were younger 
than 15 years of age at disease onset. Osiris data do not 
contain clinical information, hospitalisation, or death. 
Therefore, one of us (AR), working at the MHS with the 
highest incidence of Q fever (MHS Hart voor Brabant), 
provided hospitalisation data on the cases reported to that 
MHS. For estimating incidence we used population data 
(2007–2009) from Statistics Netherlands (CBS).
Estimated number of childhood infections
For an estimation of the number of new childhood infec-
tions during the period 2007–2009, we assumed equal 
exposure for children and adults [3, 5]. We used the adult 
seroprevalence increase (’07–’09) as an approximation 
for the seroprevalence increase in children. We used the 
2006/2007 seroprevalence data from a random sample 
(5654 participants) of the Dutch population as the pre-
epidemic control [15]. For post-epidemic adult data, we 
used the May 2010 Sanquin Blood Supply study. San-
quin tested over 40,000 serum samples of all consenting 
blood donors (18–65 years) living in the 23 postal code 
areas with the highest reported rates (23-HR-PC-areas) 
[16]. The Sanquin Blood Supply Foundation is the only 
organisation in the Netherlands authorised to manage 
the supply of blood and blood products. The 23-HR-PC-
area is situated in the northeastern part of the province of 
Noord-Brabant, with 86,025 inhabitants of which 15,935 
under the age of 15  years (<15  year: 15.6  %) in the epi-
demic years, i.e. 0.52 % of the total Dutch population of 
16.4 million, and 0.54 % of all Dutch children <15 years of 
age (2.9 million).
We calculated the expected incidence in the high risk 
regions (23-HR-PC) of new childhood infections per 
10,000 children (<15years) from the seroprevalence 
increase (from 2006 to 2010) and population data in the 
respective 23-HR-PC areas (2008) from Statistics Nether-
lands (CBS) [17].
Estimated number of possible chronic childhood infections 
2007–2009
The National Health Council of the Netherlands pub-
lished a list of pre-existing conditions that carry a risk of 
developing chronic Q fever [18]. For children, only con-
genital heart- and/or vascular disease is listed as a rele-
vant risk factor. In the Netherlands, data of children with 
congenital heart- and/or vascular disease are entered in 
the national congenital risk factors registry (CBS) [19]. 
Assuming an equal distribution of these conditions in 
the Netherlands, we estimated the potential number of 
children with congenital risk factors who could develop 
chronic Q fever after (un)detected infection in the 
23-HR-PC areas.
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Comparison with literature: overview of case reports, 
seroprevalence studies and symptom rate
We reviewed the literature of the last 65 years (from Jan-
uary 1, 1949 (first published articles) to June 30, 2014) 
and used the PubMed/Medline and Scopus databases 
with the following combined text and MeSH heading 
search strategy: “Q fever” OR “Coxiella burnetii”, with 
a restriction for age {infant [birth-23  months), child, 
preschool (2–5), child (6–12), adolescent (13–18)]/all 
child (0–18)} and language [English, Dutch, French and 
German]. Different studies used different cut-off points 
for age, therefore a limit of 18  years and a selection of 
under 16  years was used to include as many studies of 
children as possible. References were scrutinized from 
these studies to identify other relevant studies (“snow-
ball method”). We categorized articles according to the 
studied (sub-) populations i.e.: (A) general, (B) high 
exposure risk, and (C) symptomatic patients (i.e. with an 
influenza-like illness).
Results
Reported cases in the Netherlands during the epidemic 
years 2007–2009
In the period between 01/01/2007 and 01/01/2010, there 
were 3522 reported cases in The Netherlands, of which 
44 were children aged 0–14 years (1.2 %).
The 3-year Q fever reporting incidence for children aged 
0–14 years was 0.15 per 10,000 inhabitants per year com-
pared to 2.6 for adults (≥15 years). The number of cases 
increased per epidemic-year both in children and in adults; 
it showed a seasonal peak in late spring and early summer 
(Fig. 1a, b). More boys than girls were reported: 25 vs 19.
The geographical spread of childhood Q fever corre-
sponded to that of adults [20]. From the 23-HR-PC-area, 
22.7  % (10/44) children <15  years were reported, com-
pared to 27.3 % (951/3478) adults (≥15 years).
The 44 reported children predominantly had fever with 
or without a headache. In 2007 and 2008, 11/23 (45.8 %) 
had pneumonia. Clinical data were not available for 2009. 
The MHS Hart voor Brabant reported 22 (of the total 44) 
children of whom four had pneumonia (18  %, as com-
pared to 49 % in the adults); four children were referred 
to a local hospital for treatment (18  %, as compared to 
24 % in the adults); one was admitted (4.5 %; adults 17 %) 
and fully recovered with appropriate treatment. No com-
plications were reported.
Estimated number of new infections in the epidemic years 
2007–2009
The basic adult seroprevalence of Q fever antibodies in 
the pre-epidemic year 2006 was 2.4 % [21]. Post-epidemic 
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Fig. 1 Number of notified cases during the years 2007–2010 for the ages of 0–14 years and 15 years and older
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12.2  % [16]. The increase in the three epidemic years 
was thus 9.8 % for adults, and we similarly used 9.8 % for 
children. In the 23-HR-PC-area 15,935 children under 
15  years of age were living, suggesting that 1562 child-
hood infections (9.8  %) will have occurred in the three 
epidemic years. According to current literature [8, 9], 
roughly 15–50  % of infected children become sympto-
matic (including mild fever), i.e. an estimated 234–781 
children may have shown symptoms in the 23-HR-PC 
area during the three-year period. However, from the 
23-HR-PC area only 10 children were diagnosed and 
reported with Q fever in the three epidemic years.
Estimated number of possible childhood chronic Q fever 
cases
Based on numbers of General Practices [22–24], the 
National Institute of Public Health and the Environment 
(RIVM, The Netherlands) estimated the 2007 absolute 
point prevalence of congenital heart- and/or vascular dis-
ease for the age group 0–14 years as 25,232 (0.004 % of 
all children 0–14  years) [25]. In the 23-HR-PC-area we 
thus expect there to be 137 children with a condition pre-
disposing for chronic Q fever infection. If 9.8 % of these 
were indeed infected during the 3-year epidemic, we may 
expect 13 children with high-risk of developing chronic 
Q fever in the 23-HR-PC-area. So far, no children with 
chronic Q fever have been reported.
Comparison with previous reports in literature
In the medical literature, Q fever in children is supposed 
to be asymptomatic in many cases. The most described 
clinical symptoms are an abrupt onset of fever accom-
panied with respiratory and/or gastro-intestinal symp-
toms. More severe manifestations are rare, but cases 
of hepatitis, hemolytic-uremic syndrome, myocardi-
tis, pericarditis, cerebellitis, encephalitis, meningitis, 
hemophagocytosis, lymphadenitis, acalculous cholecys-
titis, osteomyelitis, vascular infection, skin disease and 
rhabdomyolysis have been described.
Case studies, outbreaks and seroprevalence studies
Throughout the world, in 42 clinical reports, 140 cases 
of children with a serious outcome were described with 
one or more organs involved. In most cases, the lungs 
(n = 80), the heart (n = 24) or the bones (n = 23) were 
affected; four children reportedly died of their com-
plications. In chronic Q fever, predominantly cardiac 
infections were described, less often neurological compli-
cations or osteomyelitis. Children have been mentioned 
in five outbreak reports, but no additional clinical data 
were given [26–30].
In 36 articles, data on Q fever seroprevalence in chil-
dren were reported: 22 in A (the general childhood 
population), 4 in B (a high exposure risk) and 10 in C 
(symptomatic patients) (Additional files 1, 2, 3: Figures 
S1–S3 are annexed in the appendix).
The seroprevalence of antibodies against C. burnetii in 
children varied between 0 and 70 % in the different stud-
ies, but the data were hard to compare because of the 
differences in methods and cut-off’s used for testing. In 
general, the studies show an increase of seroprevalence 
with age.
African studies on childhood Q fever were initially rare, 
probably because Q fever is clinically difficult to distin-
guish from other feverish diseases [31–36]. The seroprev-
alence in Africa is highest in those countries where cattle 
farming is substantial [37].
In Japanese studies, children had a considerably higher 
seroprevalence compared to all other countries [38–41].
In Europe, a sero-epidemiological study among the 
local exposed population was performed in Switzerland 
after a huge outbreak [42]. All positively tested children 
were retrospectively interviewed about Q fever symp-
toms. Only 15 % of the 577 seropositive children under 
the age of 15 reported symptoms, compared to 64  % of 
the 2459 seropositive adults [7, 43].
The Netherlands
Until now, only two epidemiologic seroprevalence inves-
tigations, described in five papers, have been performed 
in the Netherlands before [21, 44–47], three during [16, 
48, 49] and two after [6, 50] the 2007–2009 epidemic.
In the first pre-outbreak study reflecting general expo-
sure in the community, a cross-sectional seroprevalence 
study on sera from 1968, 1975, 1979 and 1983, the prev-
alence of antibodies in the age groups 1–4 (31  %) and 
5–9 years (27 %) was comparable to that in adults (24 %) 
[44]. In this study, an indirect fluorescent immune-assay 
on IgM-antibodies against C. burnetii was used for the 
first time, which is a much more sensitive test than the 
previously used agglutination test on IgM-antibodies 
against C. burnetii.
In the later 2006 pre-outbreak study the seropreva-
lence was 2.4 % in a systematic random selection of the 
general Dutch population (PIENTER 2 [15, 21]). In this 
study, only 13 of the 1799 children under the age of 
20 years showed serological markers of a previous infec-
tion (0.75 %).
In a pre-outbreak high risk seroprevalence study 
among inhabitants of dairy goat farms in 1984, 29  % of 
the children in the age group 0–14  years had IgG-anti-
bodies against C. burnetii without a recognized course of 
disease, compared to 24.5 % in the adults (>15 years) [44]. 
In the third outbreak year, the seroprevalence in high risk 
participants at dairy goat farms was 68.7 %, and for chil-
dren 12–17 years it was 57 % [48].
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Discussion
In order to inform and alert local paediatricians on the 
threat of silent chronic childhood Q fever we tried to esti-
mate the expected number of these serious infections. An 
exposure survey or seroprevalence study might give the 
best answer to the question on how many chronic child-
hood infections can be expected. These methods are costly 
and a burden to the possibly exposed children. Therefore 
we first tried to estimate the expected number based on 
literature, exposure estimates, and high-risk estimates. 
We argue that childhood Q fever was probably seriously 
underdiagnosed in the Netherlands. In this overview of 
the Dutch Q fever epidemic (with 3522 reported cases in 
the 3-year epidemic period), we show that only 44 chil-
dren (1.2 %) under the age of 15 years were reported. In 
this epidemic, Q fever did not present in the usual way as 
a disease of adult male farmers, veterinary surgeons, hide 
handlers, butchers or abattoir workers, but was transmit-
ted equally to the inhabitants of the region surrounding 
dairy goat farms, with highest attack rates for those living 
nearest to the farms. As there were no childhood seroprev-
alence studies available, we used the adult data to estimate 
the number of acute and chronic childhood infections. The 
Netherlands is one of the most densely populated coun-
tries in the world. Airborne transmission from contami-
nated dairy goat farms to the neighbouring living areas 
was the greatest source in the Dutch outbreak. Therefore, 
inhabitants of all ages were: equally exposed, causing equal 
infection-incidences in men, women and children.
We estimated the number of symptomatic children in 
the high-risk area to be over two hundred possible cases 
(range 234–781), while in this area only 10 childhood 
cases were reported.
In medical literature, wide ranges of incident cases and 
seroprevalences exist, suggesting either true differences 
or differences in awareness or diagnostic possibilities. 
Wide ranges exist not only for children and adults per 
continent, but also within one country; e.g. for Australia 
the range is 1.3–2.5 % for children and 4–21 % for adults 
[51, 52]. This could reflect local exposure differences but 
might reflect differences in awareness and/or different 
lab techniques used with different cut off values. Exam-
ple in the Richardus-study [44], using a sensitive indirect 
immune-assay on IgM-antibodies against C. burnetii [44] 
showed a seroprevalence of 15–65  %. While 20 years 
later in the 2006 study of Schimmer et al. [21] using IgG 
phase-2 antibodies against C. burnetii with an ELISA and 
corrected for confirmation with immunofluorescence, 
resulted in an estimated seroprevalence of 2.4  %. The 
high seroprevalence rates in the 80s are not corroborated 
with equally high numbers of Q fever. Therefore uncer-
tainty remains about the cut-off values in the first study 
[44], that may have resulted in much higher seropreva-
lences in both adults and children as compared to all 
other studies.
In contrast to the world literature, serious complica-
tions were not described in any of the reported children 
in The Netherlands. In the Dutch reporting system, the 
patient’s condition is not reportable other than fulfilling 
the reporting criteria. Complications may have occurred, 
without being reported to the MHS, e.g. in children pre-
senting without fever, as these do not fulfil reporting cri-
teria. However, clinical presentations in the areas with 
highest risk showed no complications in any child [2]. 
In reported children, respiratory tract infections were 
predominant whereas in the medical literature children 
frequently only present with fever, headache or gastroin-
testinal symptoms (vomiting, abdominal pain, anorexia 
and/or diarrhoea) [46, 53, 54]. Also Wielders et al. found 
in adults that Q fever presented mainly with fever, cough 
and dyspnoea, in contrast to data from France and South-
ern Spain were hepatitis dominated [55]. Possibly, Dutch 
GP’s and paediatricians, following the testing guidance, 
predominantly tested children with respiratory problems. 
Another possible explanation might be a difference in 
Coxiella strain pathogenicity. Whether specific Coxiella 
strains cause different clinical symptoms is unknown 
[56–58]. In the Dutch outbreak, closely related MLVA 
genotypes A–H were found suggesting a clonal spread of 
C. burnetii [56–58]. The clinical importance of this find-
ing remains unknown.
In the study of Porter [40], the authors mention as pos-
sible other explanation a greater sensitivity of Japanese 
children for C. burnetii. More important, the authors 
suggest that medical doctors are insufficiently aware of 
the broad variety in clinical presentations of Q fever in 
children and should test more often [40].
Contrary to acute Q fever, chronic Q fever is not notifi-
able in the Netherlands and at present there is no active 
surveillance system for chronic infections either. How-
ever, clinicians and medical microbiologists initiated a 
Dutch chronic database [59]. In this database, no child-
hood chronic Q fever was entered so far. Because chronic 
Q fever is a serious condition, it may be important to 
actively search for high-risk children in an early stage. In 
adults, the majority of proven and chronic Q fever dur-
ing the Dutch epidemic was discovered in patients with a 
vascular infection or endocarditis [59]. Only 27 % of these 
patients showed signs or symptoms of a possible previ-
ous acute Q fever. Furthermore, screening of patients 
with a history of heart valve surgery for previous Q fever, 
showed signs of acute Q fever in 20  % and chronic Q 
fever in 8 % [60]. These data suggest that chronic Q fever 
might develop in asymptomatically infected children 
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with additional risks factors such as congenital cardiac 
and/or vascular disease.
From current literature, it is unknown whether 
chronic Q fever will develop in as many children with a 
cardiac risk factor as in adults. Assuming similar risks in 
young and older adult cardiac patients, we expect that 
up to 13 children are at high risk for developing chronic 
Q fever in the area with highest risk (23-HR-PC). This 
high-risk area contributed a quarter of all reports, sug-
gesting similarly a quarter of all exposures in the coun-
try. Subsequently we may expect over 30 children at high 
risk for chronic infections in other areas in the country. 
Therefore, we urge paediatricians in the exposed areas 
(especially the southern part of the Netherlands), but 
also across the boarders in Germany and Belgium where 
a similar Coxiella is found [57], to consider the possibil-
ity of chronic Q fever in these high risk children. Once 
found, it is important to report these cases to the MHS 
in order to broaden the data on the disease burden of 
this epidemic.
Conclusion
The most common clinical presentation of Q fever in 
children is comparable to that in adults: a self-limiting 
disease with feverish symptoms. However, a high number 
of infections may have been asymptomatic and sympto-
matic cases might have gone undetected. As asympto-
matic infections in high-risk children (cardio-vascular 
disorders) might develop into chronic Q fever, paedia-
tricians should be aware of this. Vulnerable children can 
present, like adults, with exceptional and potential seri-
ous complications such as encephalitis, osteomyelitis, 
hepatitis or endocarditis. Although a rare disease, we rec-
ommend awareness of chronic Q fever in an early stage.
Express information
Q fever in children is a rare disease for most paediatri-
cians in the world, but according to local circumstances, 
paediatricians should be alert to it.
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